Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Chronic granulomatous disease (CGD) is an inherited immune system disorder that occurs when a type of white blood cell that usually helps the body fight infection, called a phagocyte, does not work properly. In CGD, the phagocytes can't kill germs that
are ingested, and cannot protect the body from bacterial and fungal infections. Children with CGD are often healthy at birth, but develop severe infections in infancy and during early childhood. Rarely, and in milder forms of the disease, the diagnosis
doesn't become clear for years or decades.
Because they are unable to fight off infections, children with CGD often get very sick from bacteria that would cause no disease in a healthy child. Children with CGD may also develop masses of inflammatory tissue called granulomas in response to chronic
infections. These granulomas usually develop in the skin, gastrointestinal tract, and genitourinary tract.
Children with CGD are treated at Dana-Farber/Boston Children's through our Blood Disorders Center. Our Center provides
comprehensive care for a wide range of non-malignant blood disorders, and our patients have access to some of the most advanced diagnostics and treatments available.
Find in-depth information on chronic granulomatous disease (CGD) on the Boston Children's Hospital website, including answers to these questions:
New Patient Appointments